PubMed · 2003 · 15 citations · 0 references
MedicineHematologyPharmacologyClinical PharmacologyHemostasisPharmacodynamicsAnticoagulant TherapyAnticoagulation TherapyHemostatic AgentsPlatelet PhysiologyThrombin GenerationThrombosis PreventionAnticoagulant MechanismsAnticoagulant PharmacologyCoagulationCoagulation Time MeasurementNatural Anticoagulant ProteinsPlasma Anticoagulant ActivityProthrombin ActivationThrombin Inhibition
OBJECTIVE: To study the effect of Erigeron breviscapus extract on anticoagulation. METHOD: Coagulation time (CT), prothrombin time (PT), platelet factor III (PF3) and euglobulin lysis time (ELT) have been used to evaluate the anticoagulation activities of Erigeron breviscapus extract. RESULT: Erigeron breviscapus extract significantly delayed CT and PT, inhibited the activity of PF3, and decreased ELT. CONCLUSION: Erigeron breviscapus extract plays an role in anticoagulation by inhibiting PF3 and prothrombin V. It can also enhance the activity of fibrimolysis.